Advertisement

Cervical Squamous Intraepithelial Lesions: A Pathologist’s Perspective

  • Charanjeet Singh
  • Grace N. KimEmail author
Chapter

Abstract

Human papillomavirus (HPV) infection is associated with cervical squamous carcinoma and adenocarcinoma and their precursors. This chapter underscores the role of pathologists in morphologic evaluation and ancillary testing of cervical tissue, which is paramount toward successful implementation of cervical cancer screening protocols. Cytohistologic criteria for the precursor lesions (low-grade squamous intraepithelial lesion, high-grade squamous intraepithelial lesion, and SMILE), along with various methods for HPV testing, are herein discussed.

Keywords

LSIL HSIL Cobas Cervista hrHPV LAST SMILE 

References

  1. 1.
    Reagan JW, Hicks DJ, Scott RB. A study of in-situ and squamous cell cancer of the uterine cervix. Cancer. 1953;6(6):1200–14.CrossRefGoogle Scholar
  2. 2.
    Reagan JW, Seidemann IL, Saracusa Y. The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix. Cancer. 1953;6(2):224–34.CrossRefGoogle Scholar
  3. 3.
    Richart RM. A theory of cervical carcinogenesis. Obstet Gynecol Surv. 1969;24(7 Pt 2):874–9.CrossRefGoogle Scholar
  4. 4.
    zur Hausen H. Papillomaviruses in the causation of human cancers—a brief historical account. Virology. 2009;384(2):260–5.CrossRefGoogle Scholar
  5. 5.
    National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. JAMA. 1989;262:931–4.CrossRefGoogle Scholar
  6. 6.
    Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205–42.CrossRefGoogle Scholar
  7. 7.
    Kurman RJ, Ellenson H, Ronnett BM. Blaustein’s pathology of the female genital tract. 6th ed. New York: Springer; 2011.CrossRefGoogle Scholar
  8. 8.
    Singh C, Manivel JC, Truskinovsky AM, Savik K, Amirouche S, Holler J, et al. Variability of pathologists’ utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations. Arch Pathol Lab Med. 2014;138(1):76–87.CrossRefGoogle Scholar
  9. 9.
    Lee C, Laimins LA, editors. The differentiation-dependent life cycle of human papillomaviruses in keratinocytes. Boston: Springer; 2007.Google Scholar
  10. 10.
    Graham SV. Keratinocyte differentiation-dependent human papillomavirus gene regulation. Viruses. 2017;9(9).  https://doi.org/10.3390/v9090245.CrossRefGoogle Scholar
  11. 11.
    Steinback A, Riemer AB. Immune evasion mechanisms of human papillomavirus: an update. Int J Cancer. 2018;142(2):224–29.Google Scholar
  12. 12.
    Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131(17):2201–21.CrossRefGoogle Scholar
  13. 13.
    Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Rev Med Virol. 2015;25(Suppl 1):2–23.CrossRefGoogle Scholar
  14. 14.
    Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH. HR-HPV E6/E7 mRNA in situ hybridization: validation against PCR, DNA in situ hybridization, and p16 immunohistochemistry in 102 samples of cervical, vulvar, anal, and head and neck neoplasia. Am J Surg Pathol. 2017;41(5):607–15.CrossRefGoogle Scholar
  15. 15.
    Thomas JT, Oh ST, Terhune SS, Laimins LA. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J Virol. 2001;75(16):7564–71.CrossRefGoogle Scholar
  16. 16.
    Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36(12):1874–82.CrossRefGoogle Scholar
  17. 17.
    Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, et al. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol. 2008;46(1):274–80.CrossRefGoogle Scholar
  18. 18.
    Nishino HT, Tambouret RH, Wilbur DC. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology. Cancer Cytopathol. 2011;119(4):219–27.CrossRefGoogle Scholar
  19. 19.
    Abreu AL, Souza RP, Gimenes F, Consolaro ME. A review of methods for detect human papillomavirus infection. Virol J. 2012;9:262.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of PathologyFlorida HospitalOrlandoUSA
  2. 2.Department of PathologyUniversity of Central FloridaOrlandoUSA
  3. 3.Department of PathologyLAC+USC Medical CenterLos AngelesUSA
  4. 4.Department of PathologyKeck Hospital of USCLos AngelesUSA

Personalised recommendations